Comparison of the efficacy of erector spinae block using bupivacaine versus ropivacaine for post operative pain relief

Comparison of the efficacy of ultrasound guided bilateral Erector spinae block using 0.25% Bupivacaine versus 0.25% Ropivacaine for post operative analgesia in patients undergoing laparoscopic surgeries under general anaesthesia - A randomised control study - ESP

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/018955

Enrollment

Registered

2019-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: bupivacaine: 0.25% , 20ml bilaterally Through Erector spinae block Control Intervention1: ropivacaine: 0.25%, 20 ml bilaterally Through Erector spinae block

Eligibility

Inclusion criteria

Inclusion criteria: -Patients who gave written informed consent. -Patients undergoing laparoscopic surgery under general anaesthesia. -Patients belonging to ASA I and II.

Exclusion criteria

Exclusion criteria: -Patients who refused to give written informed consent for Erector spinae block. -Hypersensitivity to the drugs used. -Patients with systemic illness such as uncontrolled diabetes mellitus, neuromuscular disorder. -Patients with bleeding diathesis.

Design outcomes

Primary

Measure	Time frame
Duration of Analgesia based on pilot studiesTimepoint: 60 minutes	—

Secondary

Measure	Time frame
VAS score and 24 hour analgesic requirement Timepoint: 24 hour	—

Countries

India

Contacts

Public ContactNithish S

Bangalore medical college and research institute

ranjithagangadharaiah@gmail.com9880243626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026